|Intuitive to Begin Direct Operations in India|
Intuitive pioneered, and continues to be a global leader in, the field of robotic-assisted, minimally invasive surgery with the creation of its da Vinci surgical system more than two decades ago. Now on its fourth-generation system, the
“The adoption and advancement of robotic-assisted surgery has been enabled by critical contributions from health care professionals from India,” said Intuitive CEO Gary Guthart. “As Intuitive continues to grow to serve patients, surgeons, and hospitals in India, we look forward to deepening our support of, and work with, health care professionals in their pursuit of the clinical and economic benefits robotic-assisted surgery offers.”
In support of the company’s commitment to India, Intuitive also named Mandeep Singh Kumar as its general manager. Mandeep will direct and implement Intuitive’s in-country strategy and commercial operations. He has more than 20 years of global business experience in health care, pharmaceuticals, medical devices, and advertising. Most recently, Mandeep served as the chief commercial officer for
“It is a privilege to be part of Intuitive’s journey in India, and we are committed to working with surgeons across the country to bring the benefits of robotic-assisted surgery to their patients,” said Mandeep.
Intuitive’s sixth international office will be headquartered in Bengaluru, where employees in sales, marketing, field service engineering, and business operations will be based to support customers throughout the country. More than 65 da Vinci surgical systems are currently in use in India, with surgeons performing robotic-assisted procedures in urology, gynecology, thoracic, and general surgery.
“Our customers can expect a smooth transition and even deeper collaboration opportunities between Intuitive and India’s surgical community,” said Jeroen van Heesewijk, senior vice president of global distribution at Intuitive. “We look forward to welcoming our new colleagues to the Intuitive team, as well.”
More than 60 former Vattikuti employees became a part of Intuitive India’s business. Terms of the deal were not disclosed.
About the Da Vinci Surgical System
There are several models of the da Vinci surgical system. The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery. Da Vinci systems offer surgeons high-definition 3D vision, a magnified view, and robotic and computer assistance. They use specialized instrumentation, including a miniaturized surgical camera and wristed instruments (i.e., scissors, scalpels and forceps) that are designed to help with precise dissection and reconstruction deep inside the body.
For more information, please visit the company's web site at www.intuitivesurgical.com.
Important Safety Information
This press release contains forward-looking statements, including statements regarding provisional income tax expense related to the 2017 Tax Act, the potential impact of the final resolution of provisional estimates and potential subsequent adjustments due to additional guidance from and interpretations by regulatory and standard-setting bodies, and changes in assumptions. These forward-looking statements are necessarily estimates reflecting the best judgment of the Company’s management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. These forward-looking statements should, therefore, be considered in light of various important factors, including, but not limited to, the following: the impact of global and regional economic and credit market conditions on healthcare spending; healthcare reform legislation in the United States and its impact on hospital spending, reimbursement and fees levied on certain medical device revenues; changes in hospital admissions and actions by payers to limit or manage surgical procedures; the timing and success of product development and market acceptance of developed products; the results of any collaborations, in-licensing arrangements, joint ventures, strategic alliances or partnerships; procedure counts; regulatory approvals, clearances and restrictions or any dispute that may occur with any regulatory body; guidelines and recommendations in the healthcare and patient communities; intellectual property positions and litigation; competition in the medical device industry and in the specific markets of surgery in which the Company operates; unanticipated manufacturing disruptions or the inability to meet demand for products; the results of legal proceedings to which the Company is or may become a party; product liability and other litigation claims; adverse publicity regarding the Company and the safety of the Company’s products and adequacy of training; the Company’s ability to expand into foreign markets; the impact of changes to tax legislation, guidance, and interpretations; and other risk factors under the heading “Risk Factors” in the Company’s report on Form 10-K for the year ended
PN 1048831 Rev A
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/2b7edc83-6f67-460b-8fe7-2a6bb5675dfe